XML 66 R49.htm IDEA: XBRL DOCUMENT v3.22.1
Long-Term Investments (Details) - Schedule of statements of operation - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
BioFirst [Member]    
Condensed Income Statements, Captions [Line Items]    
Net sales $ 8,808 $ 12,339
Gross profit 6,133 7,080
Net loss (498,940) (220,855)
Share of losses from investments accounted for using the equity method   (47,791)
Rgene [Member]    
Condensed Income Statements, Captions [Line Items]    
Net sales  
Gross profit  
Net loss (149,480) (95,395)
Share of losses from investments accounted for using the equity method